Bioavailability study of Vitamin K2

Phase 4

Completed

• Registration Number: CTRI/2017/09/009660
• Lead Sponsor: Synergia Lifesciences PvtLtd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

Healthy Volunteers

Exclusion Criteria

Hypersensitivity to vitamin K and consumption of fermented food in last 24 hours

Study & Design

• Study Type: BA/BE
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of Bioavailability and pharmacokinetic profile of test drugTimepoint: After study completion

Secondary Outcome Measures

Name	Time	Method
Safety of the test drugTimepoint: Throughout the study